Abstract:Objective To study the effects of extracellular-signal regulated kinase mitogenactivated protein kinase (ERK-MAPK) signaling pathway inhibition on histone phosphorylation and the related gene expression in human colorectal cancer cells.Methods Two human colorectal cancer cell lines (SW1116 and HCT116) were cultured and treated with gradient(0,20,40/μmol/L) doses of ERK-MAPK signaling pathway inhibitor U0126.Cell viability was determined by cell counting kit 8 (CCK-8) assay.Cell cycle distribution was assessed by flow cytometry.The expression levels of histone H3 kinases including ribosomal S6 serine-threonine kinase (RSK-2) and mitogen-and stressactivated protein kinase 1 and 2 (MSK1 and MSK2),and the levels of histone H3 (Ser10) phosphorylation and c-Fos protein were detected using Western blotting.Results Treatment of these two human colorectal cancer cell lines with ERK-MAPK inhibitor resulted in a time and dose-dependent inhibition of cell proliferation significantly. Proliferation rate of HCT116 was reduced to 47% at 72 hours after 40/μmol/L U0126 treatment. Cell cycle analysis showed that the percentage of phase G0/G1 cells significantly increased (P<0. 01) and the percentage of phase S cells decreased (P<0.01) after treatment with ERK-MAPK inhibitor. The expression of MSK1 and RSK2 reduced obviously in both of human colorectal cancer cell lines treated with U0126, which resulted in a 28% and 40% reduction of levels of MSK1 and RSK2 as compared with control HCT116 cells respectively,while no detectable change in the expression of MSK2 was found. Consistent with this, the expression level of histone H3 (ser10) phosphorylation was markedly down-regulated by ERK-MAPK inhibitor, and the related protein c-Fos expression decreased accordantly. Conclusions Decreased ERK-MAPK signaling pathway may reduce histone H3 (Ser10) phosphorylation via suppression of the activity of histone H3 kinase including MSK1 and RSK2, but not MSK2, consequently decrease the expression of c-Fos protein, which results in the inhibition of colorectal cancer cells proliferation.

Inhibition of DEK expression reduces proliferation of human colorectal adenocarcinoma cell line HCT116

Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells

Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer.

Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.

[Silencing of Adrm1 by RNA Interference Suppresses Proliferation of Colorectal Cancer Cells].

Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.

Oncogene DEK is Highly Expressed in Lung Cancerous Tissues and Positively Regulates Cell Proliferation As Well As Invasion.

ShRNA-mediated silencing of the epidermal growth factor receptor gene inhibits proliferation of human HCT-15 colorectal cancer cells

siRNA-mediated knockdown of hTDE2 retards cell cycle progression through transcriptional activation of p21.

Critical Role of DEK and Its Regulation in Tumorigenesis and Metastasis of Hepatocellular Carcinoma

Inhibition of the Extracellular Signal-Regulated Kinase/mitogen-Activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells.

Construction and functional characterization of alentiviralvector mediating RNA interference of DEK gene

Suppression of HCT116 cell proliferation by silencing vascular endothelial growth factor gene with RNA interference

Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells

Dieckol, a natural polyphenolic drug, inhibits the proliferation and migration of colon cancer cells by inhibiting PI3K, AKT, and mTOR phosphorylation

The Effect of Extracellular Signal-Regulated Kinases Signaling Pathway Inhibition on Histone Phosphorylation and Gene Expression in Colorectal Canoer Cells

RNA interference inhibits the proliferation of human colorectal cancer cells by blocking the expression of cyclin D1

Effects of RhoGDI2 gene silencing by siRNA on proliferation and invasion of colon carcinoma cell lines

Expression of DEPDC1 gene in pancreatic cancer and effect of siRNA on pancreatic cancer cells

DEK mediates AKT/mTOR signaling pathway promotes the proliferation, migration and EMT process of cholangiocarcinoma

Effect of knockdown of VEGF gene expression by shRNA on characteristics of human colorectal cancer cell line